CEO Message
As a pharmacist with an M.Phil in Microbiology and a Ph.D. in Biochemistry, I have dedicated over 12 years of my professional life to serving at Tertiary Care Eye Hospital. Throughout this time, I consistently observed a pressing need for a high-quality multivitamin—one that not only supports the management of Age-related Macular Retinal Degeneration (AMRD) but also protects individuals exposed to blue light due to their occupational demands.
Driven by this vision, I held detailed consultations with leading ophthalmologists from the twin cities. Together, we identified the critical nutritional gaps affecting eye health and designed a formulation that meets these needs. After thorough discussions and development, we successfully registered Ocuvit Tablet and Syrup with the Drug Regulatory Authority of Pakistan (DRAP).
Ocuvit is a carefully crafted blend of essential vitamins and minerals—supporting not only optimal eye function but also contributing to overall well-being. I am confident that Ocuvit will deliver meaningful benefits to patients and set a new standard in eye care supplementation.
May Allah (SWT) continue to guide and bless us all. Ameen.
Dr. Sohail Ahmad
Chief Executive Officer
S.A. Pharmaceuticals
Our History
S.A. Pharmaceuticals was founded with a clear vision—to bridge the gap in specialized healthcare supplements, particularly those addressing critical but often overlooked needs in eye health. The inspiration came from years of frontline experience in one of Pakistan’s most respected eye hospitals, where our founder, a pharmacist with M.Phil in Microbiology and Ph.D. in Biochemistry, identified a consistent lack of effective multivitamin support for patients at risk of visual degeneration and digital screen exposure.
After extensive research and collaboration with top ophthalmologists in the twin cities, S.A. Pharmaceuticals developed and successfully registered Ocuvit Tablet and Syrup with the Drug Regulatory Authority of Pakistan (DRAP). This marked a significant milestone in our journey—offering a scientifically balanced formulation targeting Age-related Macular Retinal Degeneration (AMRD) and blue light-induced eye strain.
Today, S.A. Pharmaceuticals stands committed to innovation, quality, and patient-centered care. With a strong foundation in pharmaceutical science and a passion for improving lives, we continue to expand our portfolio with products designed to meet real clinical needs.
Our Vision
Our aspiration is to be the most trusted and esteemed pharmaceutical innovator globally—leading the charge for a safer, more effective, and accessible healthcare future for everyone. We are dedicated to improving the quality of life within communities by maintaining the highest scientific standards, uncompromising product integrity, and unshakeable ethical principles. By driving ongoing innovation and a passion for progress, we seek to create pioneering healthcare solutions that solve genuine needs, instill confidence among healthcare professionals, and empower individuals with the ability to live healthier, more engaging lives.
Our Mission
Our vision is to investigate, develop, and produce innovative, high-quality medicines that satisfy and surpass international standards. We are obligated by an unwavering vision of ethical distinction and scientific responsibility, stimulated by the passion for discovery and advancement in medicine. Core to all that we do is a desire to make a difference for patients, deliver better quality of life, and bring effective and affordable treatments to communities everywhere. Through collaboration, compassion, and innovative science, we seek to be a respected partner in the creation of a healthier future for everyone.
